Ming Lim With Team Highlights The Importance of Identifying NSHA Patients
Ming Lim, Clinical Associate Professor at University of Utah, shared on LinkedIn:
“Using the My Life Our Future Research Repository, we analyzed the largest known cohort of individuals with non-severe hemophilia A (NSHA) who developed inhibitors (n=142). We identified 70 distinct F8 gene variants where inhibitor development occurred in a multiethnic cohort. These findings highlight the importance of identifying NSHA patients at-risk for inhibitors to improve clinical management and outcomes.
This study took years in the making, and would not have been possible without the support of the HTRS Mentored Research Award, Nigel Key, Jill Johnsen, Kristy Lee, American Thrombosis and Hemostasis Network (ATHN) and Tammuella Chrisentery-Singleton, and the My Life Our Future Research Repository.”
Title: F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia A
Authors: Ming Y. Lim, Kristy Lee, Jill M. Johnsen, Nigel S. Key
Read full article here.
Stay updated about latest Haemophilia A news with Hemostasis Today.
-
Jun 15, 2026, 17:20Megan Adediran: Small Act, Massive Impact – Celebrating Blood Donor Day
-
Jun 15, 2026, 16:52Alejandro González Veliz: A Modern Approach to Anticoagulant Management
-
Jun 15, 2026, 16:20New Therapeutic Strategies Targeting Iron Metabolism
-
Jun 15, 2026, 15:43Antonio Paul: Donor Safety Is More Than a Sterile Needle
-
Jun 15, 2026, 15:36Alejandro González Veliz: A Coronary Calcium Score of Zero Doesn’t Always Mean Zero Risk
-
Jun 15, 2026, 15:35Tareq Abadl: Your Blood Tells Your Story – Even in the Shape of Its Cells
-
Jun 15, 2026, 15:34Three Days of Learning, Collaboration, and Community at EHC 2026
-
Jun 15, 2026, 15:31Abdul Mannan: What if Our First Move in Acquired Haemophilia A is Costing Frail Patients Time?
-
Jun 15, 2026, 14:11Alba Maiques Diaz: Completion of My Tenure in the YoungEHA Committee at the EHA